Table II.
Gender | Age | Ethnicity | CTCs | ALP | Follow-up | Recurrence/metastasis | Survival | |||
---|---|---|---|---|---|---|---|---|---|---|
Spearman's rho | Gender | Correlation coefficient | 1.000 | −0.429a | −0.066 | 0.013 | −0.230 | −0.033 | −0.389 | 0.505a |
Sig. (2-tailed) | 0.041 | 0.765 | 0.952 | 0.292 | 0.882 | 0.066 | 0.014 | |||
N | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | ||
Age | Correlation coefficient | 1.000 | 0.208 | 0.357 | −0.093 | 0.214 | 0.492a | −0.232 | ||
Sig. (2-tailed) | 0.342 | 0.095 | 0.672 | 0.327 | 0.017 | 0.288 | ||||
N | 23 | 23 | 23 | 23 | 23 | 23 | 23 | |||
Ethnicity | Correlation coefficient | 1.000 | 0.094 | −0.463a | 0.014 | 0.199 | 0.120 | |||
Sig. (2-tailed) | 0.669 | 0.026 | 0.949 | 0.363 | 0.587 | |||||
N | 23 | 23 | 23 | 23 | 23 | 23 | ||||
CTCs | Correlation coefficient | 1.000 | −0.058 | 0.019 | 0.605b | 0.121 | ||||
Sig. (2-tailed) | 0.791 | 0.931 | 0.002 | 0.582 | ||||||
N | 23 | 23 | 23 | 23 | 23 | |||||
ALP | Correlation coefficient | 1.000 | −0.020 | 0.106 | −0.238 | |||||
Sig. (2-tailed) | 0.927 | 0.631 | 0.273 | |||||||
N | 23 | 23 | 23 | 23 | ||||||
Follow-up | Correlation coefficient | 1.000 | 0.126 | 0.088 | ||||||
Sig. (2-tailed) | 0.567 | 0.691 | ||||||||
N | 23 | 23 | 23 | |||||||
Recurrence/metastasis | Ccorrelation coefficient | 1.000 | −0.250 | |||||||
Sig. (2-tailed) | 0.251 | |||||||||
N | 23 | 23 | ||||||||
Survival | Correlation coefficient | 1.000 | ||||||||
Sig. (2-tailed) | ||||||||||
N | 23 |
Correlation is significant at the 0.05 level (2-tailed).
Correlation is significant at the 0.01 level (2-tailed). Significant correlations are shown in bold text.